Pharma Grade Sodium Bicarbonate Industry Size, Share & Demand
According to Future Market Insights (FMI), the worldwide pharma-grade sodium bicarbonate market share is expected to reach USD 274.8 million in 2024 and USD 387.7 million by 2034. The market is projected to rise at a CAGR of 3.5% by 2034.
The global pharma-grade sodium bicarbonate market is driven by the increasing consumption of sodium bicarbonate by the pharmaceutical industry, particularly as an active pharmaceutical ingredient (API). It is widely used in treating metabolic acidosis, hemodialysis, cardiac arrest, extracorporeal blood circulation, and uncontrolled diabetes.
Growing geriatric population is set to drive demand for sodium-based medications. API is expected to become the dominant chief ingredient in drug formulations, enhancing the capabilities of various drugs. Furthermore, the application of sodium bicarbonate for hemodialysis is also expected to increase during the forecast period.
Research and development activities are focusing on new applications of pharmaceutical-grade sodium bicarbonate. A study by the University of Liverpool and the Karolinska Institute in Sweden found that giving women pharma-grade sodium bicarbonate in addition to oxytocin increased their chances of natural vaginal delivery by 17%. This research is set to drive growth and unlatch new applications for pharmaceutical-grade sodium bicarbonate.
Source:
https://www.einpresswire.com/article/562730770/pharma-grade-sodium-bicarbonate-market-is-expected-to-reach-us-315-4-mn-by-the-end-of-2028-fmi
Key Takeaways from the Pharma Grade Sodium Bicarbonate Market Report:
The pharma-grade sodium bicarbonate market is expected to reach a value of US$ 387.7 million by 2034.
The market is projected to surge at a CAGR of 3.5% by 2034.
China's pharma-grade sodium bicarbonate market is expected to grow at a CAGR of 3.9% by 2034.
The United States is projected to rise at a CAGR of 2% in 2034.
Based on grade, the coarse segment is expected to hold a market share of 78.2% in 2024.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Pharma Grade Sodium Bicarbonate Industry Size, Share & Demand
According to Future Market Insights (FMI), the worldwide pharma-grade sodium bicarbonate market share is expected to reach USD 274.8 million in 2024 and USD 387.7 million by 2034. The market is projected to rise at a CAGR of 3.5% by 2034.
The global pharma-grade sodium bicarbonate market is driven by the increasing consumption of sodium bicarbonate by the pharmaceutical industry, particularly as an active pharmaceutical ingredient (API). It is widely used in treating metabolic acidosis, hemodialysis, cardiac arrest, extracorporeal blood circulation, and uncontrolled diabetes.
Growing geriatric population is set to drive demand for sodium-based medications. API is expected to become the dominant chief ingredient in drug formulations, enhancing the capabilities of various drugs. Furthermore, the application of sodium bicarbonate for hemodialysis is also expected to increase during the forecast period.
Research and development activities are focusing on new applications of pharmaceutical-grade sodium bicarbonate. A study by the University of Liverpool and the Karolinska Institute in Sweden found that giving women pharma-grade sodium bicarbonate in addition to oxytocin increased their chances of natural vaginal delivery by 17%. This research is set to drive growth and unlatch new applications for pharmaceutical-grade sodium bicarbonate.
Source: https://www.einpresswire.com/article/562730770/pharma-grade-sodium-bicarbonate-market-is-expected-to-reach-us-315-4-mn-by-the-end-of-2028-fmi
Key Takeaways from the Pharma Grade Sodium Bicarbonate Market Report:
The pharma-grade sodium bicarbonate market is expected to reach a value of US$ 387.7 million by 2034.
The market is projected to surge at a CAGR of 3.5% by 2034.
China's pharma-grade sodium bicarbonate market is expected to grow at a CAGR of 3.9% by 2034.
The United States is projected to rise at a CAGR of 2% in 2034.
Based on grade, the coarse segment is expected to hold a market share of 78.2% in 2024.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Chinese
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek